Reduction in proteinuria with bortezomib based therapy for antibody mediated rejection.

Clinical transplants

Volumn , Issue , 2010, Pages 437-440

  Lubetzky, Michelle ^a   Auli, Meredith J ^b   Walker, Jennifer ^b   Leeser, David ^b   Kapur, Sandip ^b   Hartono, Choli ^b   Dadhania, Darshana ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BORONIC ACID DERIVATIVE; BORTEZOMIB; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PROTEASOME; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

ADULT; ARTICLE; BIOPSY; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEINURIA; RETROSPECTIVE STUDY; SALVAGE THERAPY; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; BIOPSY; BORONIC ACIDS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNITY, HUMORAL; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEW YORK CITY; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINURIA; PYRAZINES; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 79960057099     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)